Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05508698 · ClinicalTrials.gov registry record · NA
Flu Shot Pre-visit Questionnaire
A NA study, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 230,962
- Enrollment target
NCT05508698: Completed NA study, sponsored by Geisinger Clinic.
NCT05508698 is a NA study that has completed, run by Geisinger Clinic. The registered enrollment target is 230,962 participants, above the 1,400-participant average among 58,714 other NA trials with a reported enrollment target (16397% higher). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05508698, a NA study, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 230,962 participants
- Enrollment target
Study Summary
The purpose of this study is to assess, prospectively, the effect on flu vaccination rates of a pre-visit questionnaire that asks patients to indicate their preferences for a flu shot. Responses to the questionnaire will also be shown to clinicians via additional text in an existing flu shot alert. The investigators hypothesize that the pre-visit questionnaire will lead to increased flu vaccination compared with standard practices.
Primary Outcome
Patient received a flu vaccine (yes/no) between the day questionnaires became available for the patient's first scheduled flu-shot-eligible appointment and 7 days following the appointment. Questionnaires were available 14 days prior to the appointment date for appointments scheduled at least 14 days in advance. Questionnaires were available on the day the appointment was scheduled for appointments scheduled less than 14 days in advance. Note that control patients did not receive a flu shot que
Interventions
- BEHAVIORAL Salience
- BEHAVIORAL Precommitment Nudge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 230,962 participants |
| Start Date | 2022-08-18 |
| Est. Completion | 2023-04-08 |
| Phase | NA |
What the finished NCT05508698 record still lists
NCT05508698 is an interventional study that assigns participants to a tested intervention. Its 230,962 participants enrollment target places it among the larger protocols in the corpus, above the 1,400-participant average among 58,714 other NA trials with a reported enrollment target (16397% higher).
The record links to 0 conditions, and to 2 interventions - of which Salience is the first listed.
NCT05508698 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05508698 about?
NCT05508698 is a clinical study titled "Flu Shot Pre-visit Questionnaire". The purpose of this study is to assess, prospectively, the effect on flu vaccination rates of a pre-visit questionnaire that asks patients to indicate their preferences for a flu shot. Responses to the questionnaire will also be shown to clinicians via additional text in an existing flu shot alert. ...
What is the current status of trial NCT05508698?
This trial is currently completed. It is a NA study. The enrollment target is 230,962 participants. The study started on 2022-08-18. Estimated completion is 2023-04-08.
What interventions are being tested in trial NCT05508698?
The interventions under investigation include: Salience (BEHAVIORAL), Precommitment Nudge (BEHAVIORAL).
Who is sponsoring clinical trial NCT05508698?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05508698's enrollment target sits among peer trials
230,962 1st of 2000 higher than 2,000 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04735835 · 250,000 participants · NA
Personalized Responses to Dietary Composition Trial 3
- NCT06090578 · 180,000 participants · NA
TabCAT Brain Health Assessment in Primary Care
- NCT02280733 · 300,000 participants
A Real-World Registry of Chronic Wounds and Ulcers
- NCT06694181 · 300,000 participants
Safe and Explainable AI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI